MLIV Research, funded by the ML4 Foundation, supports collaborative scientific projects to advance understanding and therapy development for mucolipidosis type IV.
Investigator Initiated Research Programs support researchers studying lipedema, funding basic and translational work to advance diagnostics and lay foundations for clinical trials and new therapeutics.
The Investor-Initiated Research Grants from Beyond Batten Disease Foundation fund global research to advance understanding and treatment of juvenile Batten (CLN3) disease.
The CDKL5 Pilot Grant Programme from the Loulou Foundation funds innovative research to advance understanding and therapy development for CDKL5 Deficiency Disorder.
James T. Lubin Fellowship supports clinicians through combined clinical care and research training to improve care for rare central nervous system neuroimmune disorders and develop future academic leaders.
The SMA Foundation Research Funding program supports projects that accelerate late-stage translational research or clinical trials for new SMA therapeutics.